| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |